Nanofiber Quantum Technologies, Inc.
16.9.2023 01:02:24 CEST | ACCESS Newswire | Press release
PALO ALTO, CA / ACCESSWIRE / September 15, 2023 / Nanofiber Quantum Technologies Inc. ("NanoQT") raised $8.5m from leading venture capital investors. Phoenix Venture Partners (PvP) in the US, and Japan's JAFCO Group Co Ltd, SPARX Group Co Ltd, Keio Innovation Initiative, Inc. (KII), and Waseda University Ventures (WUV) financed the round through convertible notes.
Founded in 2022, NanoQT is a leading startup company focused on fiber connectable quantum computing hardware. Unlike superconducting circuits and ion traps for quantum computing, NanoQT uses a technology called nanofiber cavity Quantum Electrodynamics (QED). This technology has been derived from over a decade of intensive research by Professor Takao Aoki at Waseda University, Japan, a leading expert in quantum computing and co-founder of NanoQT.
NanoQT owns a novel and proprietary quantum processing unit (QPU) that employs neutral atoms and photons as qubits, capable of processing and storing quantum information while communicating with other QPUs. Modularity and scalability of interconnected QPUs offer a unique platform for distributed quantum computing and quantum networks for a variety of useful applications. NanoQT's QPU aims to revolutionize quantum computing.
"While cavity QED has long been a recognized platform in quantum computing, developing the ideal cavity posed significant challenges. We've overcome these challenges using our proprietary QED technology," comments Dr. Akihisa Goban, NanoQT's CTO and co-founder, who studied cavity QED technologies under Professor Jeff Kimble at Caltech.
"We are thrilled with the support from our US and Japanese investors. We aim to spotlight our unique approach and its strengths. With the funding, our primary objective is to develop our proprietary QPU for quantum repeaters, an innovation not yet seen in the market," proclaims Dr. Masashi Hirose, NanoQT's CEO and co-founder, an MIT graduate and former McKinsey and Company consultant.
"For PvP, investing in NanoQT isn't merely another venture investment. This is our first investment in a Japan-origin startup. We are deeply impressed by NanoQT's innovative approach in the quantum hardware sector and are pleased to support their US expansion," expresses Dr. Nobi Kambe, General Partner of PvP.
"Our confidence in NanoQT's potential comes from its leadership. The investment is rooted in our belief in NanoQT's management team led by Dr. Hirose and Dr. Goban. We're confident they can assemble a global team well beyond Japan," comments Keisuke Miyoshi, the President and CEO of JAFCO.
Takaki Demichi, Director and Head of Mirai Creation Investment (SPARX), has a similar sentiment. "NanoQT's distinct approach doesn't just introduce novelty. It crucially addresses the longstanding challenge of connectivity, enhancing the scalability of quantum computers."
Naoji Nomura, Principal of KII, emphasizes that "NanoQT is an outstanding startup with extremely high potential for the global social implementation of moonshot-class quantum network technology, developed over many years at Japanese universities."
Dr. Hiroaki Ohta, General Partner of WUV, mentioned, "We are delighted to invest again, having supported NanoQT since the seed round. NanoQT has shown significant growth, especially in terms of collaborations, the R&D team, and intellectual property, which are fundamental for a hardware startup."
Fueled by this funding, NanoQT plans to accelerate its R&D, onboard talent from the US and Japan, and foster collaborations with academia and private corporations. With the Japan-US synergy, armed with cutting-edge technology, and oriented towards US-Japan collaborations, NanoQT aspires to exemplify global collaboration in the quantum computing field.
About Nanofiber Quantum Technologies, Inc.
Nanofiber Quantum Technologies (NanoQT) is a technology company that develops quantum processing units (QPU) using a novel and proprietary nanofiber cavity Quantum Electrodynamics (QED) system. NanoQT aims to develop connected QPUs that operate as quantum repeaters and distributed computational units. NanoQT currently operates in Tokyo, Japan, and California, US.
Nanofiber Quantum Technologies, NanoQT, and logo are trademarks of Nanofiber Quantum Technologies, Inc.
Contact Information
Dai Tsukada
Head of Operations
info@nano-qt.com
SOURCE: Nanofiber Quantum Technologies Inc.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.View source version on accesswire.com:
https://www.accesswire.com/782714/quantum-computing-startup-nanofiber-quantum-technologies-secures-85m-funding
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
RE Royalties Announces Second Tranche Investment of $800,000 in Solaris Energy's U.S. Distributed Generation Solar Portfolio9.2.2026 23:00:00 CET | Press release
All amounts in US dollars unless otherwise stated. VANCOUVER, BC / ACCESS Newswire / February 9, 2026 / RE Royalties Ltd. (TSX.V:RE)(OTCQX:RROYF)(FSE:Y2V) ("RE Royalties" or the "Company") is pleased to announce a further USD $800,000 investment toward the purchase of royalties on two portfolios of distributed generation ("DG") solar projects located throughout the United States being developed by Solaris Energy Inc. ("Solaris"). The Royalty Purchase for Portfolio 1 totals USD $4.8 million, of which USD $3 million was funded at closing, as announced on January 7, 2026. The Company expects to fund the remaining USD $1 million by Q2 2026, subject to the satisfaction of applicable conditions. The Royalty Purchase for Portfolio 2 is subject to the completion of due diligence to the satisfaction of the Company, other customary closing conditions, and is expected to occur later in the year, bringing the total portfolio level royalty investment to USD $9 million. The Royalty Rate will be adju
UK-Based Vesalic Limited Emerges from Stealth with Landmark Discovery of Potential Non-CNS Driver of Motor Neuron Diseases, including ALS, and Breakthrough Therapeutic and Diagnostic Opportunities9.2.2026 06:00:00 CET | Press release
This groundbreaking discovery has revealed a systemic metabolic dysfunction that creates a toxic exosome cargo in ALS patients, which is carried to the CNS, where it binds to and damages neurons Vesalic is pioneering a novel therapeutic to intercept and neutralise these toxins, potentially slowing or halting progression of monogenic and sporadic forms of ALS In addition, Vesalic has discovered a disease-specific alteration of the lipid composition in the membranes of exosomes circulating in the blood, and has developed a highly accurate biomarker-based technology to detect both monogenic and sporadic ALS Based on its novel biomarker discoveries, Vesalic is also applying its biomarker technology for other neurodegenerative diseases, including Alzheimer's and Parkinson's LONDON, UK / ACCESS Newswire / February 9, 2026 / Vesalic Limited, an early-stage neurodegenerative disease-focused biotech company, today emerged from stealth with the landmark discovery of a systemic process - largely
Innodata to Report Fourth Quarter and Fiscal Year 2025 Results5.2.2026 14:30:00 CET | Press release
NEW YORK, NY / ACCESS Newswire / February 5, 2026 / INNODATA INC. (Nasdaq:INOD) today announced that it will report Fourth Quarter and Fiscal Year 2025 results after the market closes on Thursday, February 26, 2026. A news release will be available in both the News and Investor Relations sections of the Innodata website, www.innodata.com. Innodata has scheduled an investor conference call for 5:00 PM Eastern time on that same day. The call-in numbers for the conference call are: (+1) 800 549 8228 North America (+44) 800 279 7040 United Kingdom (+1) 289 819 1520 International Participant Access Code 27117 # Replay dial-In (+1) 888 660 6264 North America (+1) 289 819 1325 International: Replay Passcode 27117 # Investors are also invited to access a live Webcast of the conference call at the Investor Relations section of Innodata's website at https://investor.innodata.com/events-and-presentations/. Please note that the Webcast feature will be in listen-only mode. Call-in replay will be av
Datavault AI Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2025 Accomplishments and Outlook for 20265.2.2026 12:00:00 CET | Press release
Datavault AI signed $49M of Tokenization and Technology Licensing agreements in Q4'25 that impact FY2025 and FY2026 Revenue. Revenue: Datavault AI expects at least $30 million in revenue for FY2025, compared to $2.7 million in FY2024. This represents an increase of more than 1,000% growth in our revenue over 2024. The Company continues to expand to drive substantial near- and long-term accretion to our cash flows and earnings with a revenue target for 2026 of at least $200 million. PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / February 5, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI" or the "Company"), a leader in data monetization, credentialing, digital engagement and real-world asset (RWA) tokenization technologies, today issued a letter from Nathaniel Bradley, its Chief Executive Officer, to its stockholders highlighting the Company's accomplishments in 2025 and its outlook for 2026. A MESSAGE FROM OUR CHIEF EXECUTIVE OFFICER Dear Datavault AI Stockholders, I would like t
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release
Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
